Physician profile
Timothy Feldheim
NPI 1013363506
$29,413.11
in general payments reported to CMS, 2019-2025
24 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $247 · 2021: $7,640 · 2022: $13K · 2023: $7,384 · 2024: $582 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,483 · Travel and Lodging: $2,902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,482.85 |
| Travel and Lodging | $2,902.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,058.22 | 2021-2024 | Synchromedii, Intellis Adaptivestim, Accurian |
| Boston Scientific Corporation | $6,259.42 | 2019-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Saluda Medical Americas, INC. | $3,492.60 | 2023-2025 | Evoke Scs, Evoke |
| Abbott Laboratories | $3,269.98 | 2019-2025 | Proclaim, Eterna |
| Mml US, INC. | $2,331.38 | 2021-2023 | Reactiv8 |
| Spinal Simplicity, LLC | $1,573.28 | 2022 | |
| Stimwave Technologies Incorporated | $597.35 | 2021-2022 | |
| Nevro Corp. | $520.08 | 2021-2022 | |
| Spr Therapeutics, INC | $397.16 | 2019-2022 | |
| Vertos Medical, INC. | $264.14 | 2022 | |
| Axonics, INC. | $130.31 | 2022 | |
| Stryker Corporation | $87.75 | 2023-2025 | Augment Injectable, Spinejack |
| Collegium Pharmaceutical, INC. | $82.78 | 2022-2023 | Belbuca, Xtampza |
| Tersera Therapeutics LLC | $71.14 | 2022-2023 | Prialt |
| Amgen INC. | $50.03 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $32.46 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceutical Holding Company LTD. | $31.72 | 2022 | |
| Hikma Pharmaceuticals USA | $28.66 | 2022 | |
| Scilex Pharmaceuticals INC. | $25.29 | 2023 | Ztlido |
| Biohaven Pharmaceuticals, INC. | $24.95 | 2021 | |
| Relievant Medsystems, INC. | $23.19 | 2020 | |
| Abbvie INC. | $21.69 | 2022 | |
| Pfizer INC. | $20.53 | 2023 | |
| Medtronic USA, INC. | $19.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Feldheim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.